Current Drug Metabolism
Title:Editorial: Challenges in the Treatment with New Oral Anticoagulants
Volume: 18 Issue: 7
Author(s): Peter Kubisz and Lucia Stanciakova
Affiliation:
Export Options
About this article
Cite this article as:
Kubisz Peter and Stanciakova Lucia , Editorial: Challenges in the Treatment with New Oral Anticoagulants, Current Drug Metabolism 2017; 18 (7) . https://dx.doi.org/10.2174/138920021807170906155816
DOI https://dx.doi.org/10.2174/138920021807170906155816 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
25
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Genetic Basis of Renal Mass in Rat Models
Current Hypertension Reviews A Comparative Assessment of Metabolic Syndrome and its Association with Vitamin D and Other Risk Factors in Type 2 Diabetes Mellitus Patients
Current Diabetes Reviews REM Sleep Behavior Disorder and Narcolepsy
CNS & Neurological Disorders - Drug Targets A Systematic Review on Levosimendan in Paediatric Patients
Current Vascular Pharmacology Antioxidant Therapy for Prevention of Inflammation, Ischemic Reperfusion Injuries and Allograft Rejection
Cardiovascular & Hematological Agents in Medicinal Chemistry An Evidence-Based Systematic Review of Stevia by the Natural Standard Research Collaboration
Cardiovascular & Hematological Agents in Medicinal Chemistry Effects of Pregnancy-induced Insulin Resistance on the Fetus and the Future Development of Metabolic Diseases in Adulthood
Current Vascular Pharmacology Fc-Independent Phagocytosis: Implications for Intravenous IgG Therapy in Immune Thrombocytopenia
Cardiovascular & Hematological Disorders-Drug Targets Cyclooxygenase and Atherosclerosis: A Smoking Area
Current Pharmaceutical Design Orthostatic Hypotension: Evaluation and Treatment
Cardiovascular & Hematological Disorders-Drug Targets Nano- and Biotechnological Approaches in Current and Future Generation of Cardiovascular Stents
Current Nanoscience Emerging Evidence for Neurotensin Receptor 1 Antagonists as Novel Pharmaceutics in Neurodegenerative Disorders
Mini-Reviews in Medicinal Chemistry Stem Cell Implantation for Myocardial Disorders
Current Drug Delivery Calcium and Vitamin D Supplementation. Myths and Realities with Regard to Cardiovascular Risk
Current Vascular Pharmacology Statins for the Prevention of First or Recurrent Stroke
Current Vascular Pharmacology Exercise-Induced Cardiac Troponin Release: Real-Life Clinical Confusion
Current Medicinal Chemistry Endothelial Dysfunction and Coronary Atherosclerosis
Current Drug Targets - Cardiovascular & Hematological Disorders Control of Risk Factors for Cardiovascular Disease among Multinational Patient Population in the Arabian Gulf
Current Vascular Pharmacology Cardiotonic Steroids: Novel Mechanisms of Na+ i-Mediated and - Independent Signaling Involved in the Regulation of Gene Expression, Proliferation and Cell Death
Current Hypertension Reviews Inflammatory Responses in Brain Ischemia
Current Medicinal Chemistry